Evidence check: Hormoncheck Frauen in the context of Langlebigkeit

A hormone check for women in the context of longevity is often marketed as an anti-aging tool, but the scientific evidence is weak. While hormone levels such as estrogen, progesterone, testosterone, DHEA, and cortisol do change with age and are associated with age-related symptoms, no validated biomarker panel can reliably predict individual lifespan from hormone values alone. Most commercial offerings rely on mechanistic or animal data, not on randomized controlled human trials. Hormone measurements are time-of-day dependent, cycle-dependent, and show high intra-individual variability. Hormone replacement therapy (HRT) carries risks such as thrombosis and breast cancer, especially when used without clear medical indication. Without clinical symptoms or a physician’s guidance, a hormone check for longevity optimization is not recommended. The Hallmarks of Aging (López-Otín 2013/2023) mention hormones only indirectly via altered intercellular communication, not as a standalone marker. Conclusion: Hormone checks for women currently lack sufficient evidence in the longevity context. They should not be used as the sole basis for anti-aging interventions.